Correlation Between Aerovate Therapeutics and BioMark Diagnostics
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and BioMark Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and BioMark Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and BioMark Diagnostics, you can compare the effects of market volatilities on Aerovate Therapeutics and BioMark Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of BioMark Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and BioMark Diagnostics.
Diversification Opportunities for Aerovate Therapeutics and BioMark Diagnostics
-0.84 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aerovate and BioMark is -0.84. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and BioMark Diagnostics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BioMark Diagnostics and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with BioMark Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BioMark Diagnostics has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and BioMark Diagnostics go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and BioMark Diagnostics
Given the investment horizon of 90 days Aerovate Therapeutics is expected to under-perform the BioMark Diagnostics. In addition to that, Aerovate Therapeutics is 1.05 times more volatile than BioMark Diagnostics. It trades about -0.02 of its total potential returns per unit of risk. BioMark Diagnostics is currently generating about 0.01 per unit of volatility. If you would invest 15.00 in BioMark Diagnostics on September 12, 2024 and sell it today you would earn a total of 0.00 from holding BioMark Diagnostics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Aerovate Therapeutics vs. BioMark Diagnostics
Performance |
| Timeline |
| Aerovate Therapeutics |
| BioMark Diagnostics |
Aerovate Therapeutics and BioMark Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and BioMark Diagnostics
The main advantage of trading using opposite Aerovate Therapeutics and BioMark Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, BioMark Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioMark Diagnostics will offset losses from the drop in BioMark Diagnostics' long position.| Aerovate Therapeutics vs. Adagene | Aerovate Therapeutics vs. Acrivon Therapeutics, Common | Aerovate Therapeutics vs. Rezolute | Aerovate Therapeutics vs. AN2 Therapeutics |
| BioMark Diagnostics vs. Neuronetics | BioMark Diagnostics vs. Intelligent Bio Solutions | BioMark Diagnostics vs. Biodesix | BioMark Diagnostics vs. Precipio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges |